Leukaemia/Lymphoma RNA Sequencing (Fusion Gene and SNV/Indel) Panel
Requires patient informed consent
Test details
This next-generation sequencing (NGS) panel analyses RNA samples for single nucleotide variants (SNVs), short insertions/deletions (indels), or fusion transcripts associated with leukaemias, lymphomas and other haematological malignancies.
The panel encompasses targets in over 199 genes relating to lymphoid and myeloid malignancies. By using gene-specific primers to amplify into molecular barcodes ligated onto the cDNA fragment ends, both known and novel fusions can be identified.
Profile details
The Leukaemia / Lymphoma RNA Sequencing panel is an Anchored Multiplex PCR (AMP™)- based next-generation sequencing (NGS) panel to detect and identify fusions, point mutations and expression levels from ribonucleic acid (RNA) input. The panel encompasses targets in over 199 genes relating to lymphoid and myeloid malignancies. By using gene-specific primers to amplify into molecular barcodes ligated onto the cDNA fragment ends, both known and novel fusions can be identified.
Code
PHFP
Sample Reqs
A
Turnaround
2 weeks
Special instructions
No special instructions.
Sample type guide
A
Lavender Vacutainer, EDTA anticoagulant, 4ml/6ml (6ml EDTA tubes are used for specific PCR assays)
Related specialties
Additional information